AVALO THERAPEUTICS, INC. (AVTX)

SEC filing

AVALO THERAPEUTICS, INC.

AVTX · CIK 1534120

4 · Aug 19, 2026 · Chief Financial Officer Sullivan Christopher Ryan sold 72.72K shares at $19.94/share ($1.5M); exercised options for 143.70K shares

Chief Financial Officer Sullivan Christopher Ryan sold 72.72K shares at $19.94/share ($1.5M); exercised options for 143.70K shares

xslF345X06/form4-08192026_040813.xml

xslF345X06/form4-08192026_040813.xmlSEC.gov

Graphics and non-inline formats (not embedded below).